Pokeweed Antiviral Inhibits HIV
WESTPORT, Conn-Researchers from the Parker Hughes Institute in St. Paul, Minn, have found that pokeweed antiviral protein (PAP) inhibits HIV-1without injuring sperm or female genital tract epithelial cells.
The nonspermicidal antiretroviral treatment could allow pregnancy of women in couples where the male partner is HIV-positive without putting the mother and fetus at risk of contracting the viral infection.
PAP comes from purified leaves of Phytolacca Americana and has shown broad antiviral activity against a number of pathogenic viruses. It has shown to protect against HIV-1, herpes simplex virus, and cytomegalovirus.
The discovery is important because it is a potent antiviral agent that has no adverse effects on either sperm function or female genital-tract epithelial cells, making it a fitting ingredient for spermicides.
PAP is said to directly inactivate the virus as well as interrupt the virus life cycle under conditions that do not affect sperm function.
Information from: www.hivandhepatitis.com
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
